Article
[KPC carbapenemases: what is at stake in clinical microbiology?].
Pathologie-biologie - 1 Feb 2010
Cuzon G, Naas T, Nordmann P
Abstract excerpt
Emergence and dissemination of carbapenem resistance in the world represent a significant threat for management of hospital-acquired infections. From the early 2000s, Enterobacteriaceae that produce Klebsiella pneumoniae carbapenemases (KPC) have initially been reported from the USA and now world...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
